|
1. Grant Awards in Cycle XXIII and XXIV |
|
|
1.1 Grant Awards in Cycle XXIII |
|
Dr Dany Anglicheau
Necker Hospital, Paris, France |
Non-invasive Biomarkers of Renal Allograft Fibrosis |
Dr Christian Brander
AIDS Research Institute Irsicaixa, Barcelona, Spain |
A Second Shot at HCV: The Impact of HLA Mismatch for Viral Control Post-OLT |
Dr Mandy L. Ford
Emory University, Atlanta, USA |
Role of Memory T Cells in Transplant Rejection |
Dr Thomas D. Friedrich
Albany Medical College, Albany, USA |
Preventing PVAN by Inhibiting Enzymes in the Host-cell DNA-damage Response |
Dr Peter M.A. Hopkins
The Prince Charles Hospital, Brisbane, Australia |
Non-cultured Bacteria Hold the Key to Development and Progression of Rejection in Lung Transplant Patients |
Dr Benjamin Medoff
Massachusetts General Hospital, Boston, USA |
The Role of the Immune Protein TIM3 in Lung Transplantation |
Dr Markus Selzner
Toronto General Hospital, Toronto, Canada |
Oxygenated ex vivo Liver Perfusion as a Novel Technique for Organ Storage, Assessment, and Repair |
Prof. Jean-Paul P. Soulillou
ITERT-INSERM U643, Nantes, France |
The Role of B Cells in Patients Who Accept Their Kidney Graft without Any Treatment |
|
|
|
|
1.2 Grant Awards in Cycle XXIV |
|
Dr Menna Clatworthy
Cambridge Institute for Medical Research, Cambridge, UK |
Genetic Variation in FCGR2B and Renal Transplant Survival |
Assoc. Prof. Maher Gandhi
Queensland Institute of Medical Research, Brisbane, Australia |
Optimizing the Treatment of Lymphomas that Occur after Transplantation |
Prof. Hermann-Josef Gröne
German Cancer Research Center, Heidelberg, Germany |
New Treatment Option for Chronic Transplant Dysfunction |
Dr Seth Karp
Beth Israel Deaconess, Boston, USA |
Identifying Transplantable Organs to Expand the Donor Pool |
Prof. Rajiv Khanna
Queensland Institute of Medical Research, Herston, Australia |
Virus-specific Killer T cells: A Double Edged Sword in Organ Transplantation |
Dr Cristina Legido-Quigley
King's College London, London, UK |
Are Steroids, which Have Been Oxidised, Markers of Liver Quality for Transplant? |
Dr Nazia Selzner
Toronto General Hospital, Toronto, Canada |
Improving Outcomes of Hepatitis C-infected Patients after Liver Transplantation |
Prof. Thomas K. Wadell
University Health Network, Toronto, Canada |
Lung Progenitor Cells in Tissue Repair and Prevention of Allograft Rejection |
Dr Emmanuel Zorn
Massachusetts General Hospital, Boston, USA |
Analyzing the Development and Function of “Non-specific” Antibodies in the Blood of Kidney Transplant Recipients |